Traditional

medicine

CGHS beneficiaries to avail health benefits of traditional medicine systems also

All CGHS beneficiaries—serving as well as pensioners— will now be able to avail the health benefits of alternate traditional systems  with the Union Health Ministry approving a proposal to empanel such Centres of Ayurveda, Yoga and Naturopathy under the Government health scheme.

“Private Day Care Therapy centers of Ayurveda, Yoga and Naturopathy will be empanelled under the CGHS shortly, in a manner similar to empanelment of similar day care centres of conventional (Allopathy) medicine already provided under the CGHS,” said an official from the Ministry.

Initial empanelment of  day care therapy centres will be undertaken on pilot basis for Delhi and NCR for a period of one year and subsequently would be considered for other places.

The official said that the step has been taken keeping in view of the growing popularity of AYUSH system of medicines amongst the public at large and all CGHS beneficiaries. The aim of the scheme is to improve the health and wellbeing, reduce health care expenditure and provide excellence in service delivery, efficiency, and comfort to the patients.

The treatment procedure requiring a short duration of stay in the Day Care Therapy Centre, ranging from a few hours to less than a Day will be made available to CGHS beneficiaries under this scheme.

“As the treatment procedure does not require overnight stay in the unfamiliar environment, it is extremely convenient for children and elderly patients,” said the official.

At present treatment of approved procedures like Panchkarma and Abhyanga etc. is given only after hospitalization in CGHS empanelment hospital.

Source Article

Read More
medicine

Traditional Chinese Medicine Market is Driven by Rise in Popularity among Major Population from all Across the World

Global Traditional Chinese Medicine Market: Snapshot

In recent period, the major population from all across the world is inclined toward the use of traditional Chinese medicines. As a result, the traditional Chinese medicine market is experiencing notable expansion opportunities.

The traditional Chinese medicines are found to be helpful in protecting an individual’s cognitive health, maintaining their strength as well as flexibility. As a result, they are gaining popularity among major population from all across the world. This factor will drive the growth of the traditional Chinese medicine market in the years to come.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78855

TMR’s upcoming research report on the traditional Chinese medicine market focuses on providing in-depth study of diverse important factors shaping the future of this market. It includes study of challenges, drivers, restraints, and opportunities in the market for traditional Chinese medicine. Apart from this, the report delivers dependable data on shares, volume, and revenues of the market for traditional Chinese medicine. Thus, the report is a valuable handbook for all entities working in the traditional Chinese medicine market during the forecast period of 2020 to 2030.

The global traditional Chinese medicine market is segmented on the basis of various key factors such as product type, application, and region. Based on product type, the market for traditional Chinese medicine is bifurcated into Chinese herbal medicine and acupuncture and Tai Chi.

Global Traditional Chinese Medicine Market: Growth Dynamics

The traditional Chinese medicine market is witnessing prominent growth avenues on the back of increased acceptance from various developed and developing countries. The world is witnessing noteworthy growth in the number of older populace. This factor is pushing the market growth. This aside, the improved disposable income of major people in the world is expected to drive the growth of the traditional Chinese medicine market.

Growing urbanization, technological advancements in healthcare sector, and presence of favorable health insurance policies are some of the key factors stimulating the growth opportunities in the traditional Chinese medicine market. This aside, presence of favorable government policies will support the growth of the market for traditional Chinese medicine in the years ahead.

Request for Analysis of COVID-19 Impact on Traditional Chinese Medicine Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78855

Global Traditional Chinese Medicine Market: Notable Development and Competitive Analysis

The traditional Chinese medicine market witnesses presence of gamut of players. As a result, the competitive landscape of the market for traditional Chinese medicine is highly intense. To sustain in this scenario, gamut of vendors working in this market are executing diverse strategies. Many players are growing their expenditure on research and development activities. This aside, many vendors are engaged in the launch of new products. All these activities connote that the traditional Chinese medicine market will experience remarkable growth in the upcoming years.

The list of key players in the traditional Chinese medicine market includes:

  • Apicare Pain Clinic
  • Tongrentang Hospital
  • Beijing Chinese Medicine Hospital
  • Dongzhimen Hospital
  • Beijing Hua Kang Hospital
  • Mayo Clinic
  • YinOvaCenter and WOTCM

Pre Book Traditional Chinese Medicine Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=78855&ltype=S

Read More
medicine

Understanding traditional Chinese medicine can help protect species

Demystifying traditional Chinese medicine for conservationists could be the key to better protecting endangered species like pangolins, tigers and rhino, according to University of Queensland-led researchers.

UQ PhD candidate Hubert Cheung said efforts to shift entrenched values and beliefs about Chinese medicine are not achieving conservation gains in the short term.

He said a better understanding of traditional practices was critical for conservationists to form more effective strategies.

“The use of endangered species in traditional Chinese medicine threatens species’ survival and is a challenge for conservationists,” Mr Cheung said.

“Pushing messages of inefficacy, providing various forms of scientific evidence or promoting biomedical alternatives doesn’t seem to be drastically influencing decisions and behaviours.

“And, although many practices and treatments continue to be criticised for lacking scientific support, the World Health Organization approved the inclusion of traditional Chinese medicine in its global compendium of medical practices last year.

“The challenge now is for conservationists to work proactively with practitioners and others in the industry to find sustainable solutions.

“However, most conservation scientists and organisations are unfamiliar with traditional Chinese medicine, which makes it difficult to devise effective and culturally-nuanced interventions.”

The researchers have examined the core theories and practices of traditional Chinese medicine, in a bid to make it more accessible.

They hope their study – and the nuances within – will influence policy and campaigning.

“Today, traditional Chinese medicine is formally integrated into China’s healthcare system, and has been central to China’s response to the ongoing pandemic,” Mr Cheung said.

“In fact, the Chinese government’s COVID-19 clinical guidance has included recommendations for the use of a product containing bear bile, which has raised concerns among conservation groups.”

UQ’s Professor Hugh Possingham said traditional Chinese medicine was now not only entrenched in the social and cultural fabric of Chinese society, but also gaining users elsewhere.

“A better understanding of traditional Chinese medicine will empower conservationists to engage more constructively with stakeholders in this space,” Professor Possingham said.

“We’re hoping that this work can help all parties develop more effective and lasting solutions for species threatened by medicinal use.”

###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Source Article

Read More
medicine

A review of Traditional Chinese herbal medicine in management of COVID-19

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over 59.65 million people worldwide and claimed the lives of over 1.4 million. The virus, first detected in late December 2019 in Wuhan, China, is the most significant public health problem since the 1918 Spanish flu pandemic. There are no effective and safe drugs that can be used to treat COVID-19 disease nor vaccine to prevent SARS-CoV-2 infection. Since the first cases were detected in Wuhan, several traditional Chinese herbal medicines have been used to treat this infection.

Now researchers led by David Lee from Bio-Organic and Natural Research Laboratory, McLean Hospital, Harvard Medical School, Belmont have summarized the experiences with the use of traditional Chinese herbal medicines for the management of COVID-19. Their study titled, “Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis,” was published in the January 2021 issue of the journal Phytomedicine.

Study: Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis. Image Credit: Dragon Images / Shutterstock

Background

China has a rich history of traditional herbal medicines. Traditional Chinese herbal medicine (TCM) has been used for over 5,000 in over 300 epidemics that the nation has faced. When the COVID-19 pandemic emerged early this year, treatment with TCM was reported to have been used with over 90 percent efficacy.

Study particulars

This study was a systematic review of several traditional Chinese herbal medicines that were used in Wuhan,  looking at their efficacy in the management of COVID-19. At present, patients admitted to hospitals (except TCM hospitals) are primarily treated with western medicine as frontline treatment.

Principles of TCM use

The western medications used include antibiotics and painkillers. At present, over 100 herbal TCM formulae are available for use in epidemic related infections. Authors write, “TCM is now credited for the successful battle against COVID-19 in China”.

The ancient Chinese medical text Huangdi Neijing explains that 12 meridian lines run through the human body and help balance the immune system and provide good health. The lung meridian line interconnects with the large intestine functionally and controls the body fluid (water). The researchers write, “Expelling phlegm and relaxing the bowels with laxatives are common methods for treating lung diseases. Therefore, maintaining a smooth and open channel is an important function served by the lung meridian line.” Treatment of COVID-19 is basically to “expel the toxic moisture from the upper respiratory system and to improve intestinal obstruction.” They added that the TCM method of treatment tries to maintain the balance of the lung meridian system and to restore the lung and large intestine balance using acupuncture and herbal medicine.

Treatment of COVID-19 using TCM

TCM has been used as a first-line treatment for COVID-19 disease since the emergence of SARS-CoV-2. Qingfei Paidu decoction for example, has been used in a three-day course leading to an over 90 percent efficacy.

The team of researchers wrote, “The Chinese government announced that TCM is one of the recommended therapeutic options for the treatment of COVID-19 in the third version COVID-19 treatment guidelines, published on January

Read More
medicine

Backlash after India grants permission for traditional medicine practitioners to perform surgery

The Indian government has formally granted permission for practitioners of Indian traditional medicine, known as Ayurveda, to perform surgeries, in a move that has provoked a strong reaction from doctors across the country.



a group of people standing in front of a crowd


© Provided by The Independent


Ayurveda is a traditional system of medicine practised across the Indian subcontinent which uses diet, herbal treatments, yogic breathing and other techniques for healing.

The controversial move now sanctions practitioners of the traditional system to perform a variety of general surgeries including ENT (ear nose and throat procedures), ophthalmological and dental procedures after training.

As per the new rules, training modules for surgical procedures will be added to the curriculum of Ayurvedic studies for the first time, the notification from the government said.

However, the decision has antagonised India’s biggest association of doctors, the Indian Medical Association (IMA) which described the move as equivalent to “corrupting the entire health system of the country”.

“Such mixing of the systems will be resisted at all costs,” it said in a statement. “All over India students and practitioners of modern medicine are agitated over this violation of mutual identity and respect.

“The CCIM [Central Council of Indian Medicine] should develop its own surgical disciplines from its own ancient texts… it should not claim the surgical disciplines of modern medicine as its own. Such a deviant practice is unbecoming of a statutory body,” IMA’s statement said.

Following the backlash, the government ministry of Ayush (Ayurveda, Yoga, Unani, Siddha and Homoeopathy) clarified on Sunday that “the notification is specific to 58 specified surgical procedures and doesn’t allow Shalya [general surgery] and Shalakya [Surgery for ear, nose, throat, head and eye] post-graduates to take up any other surgeries,” reported ANI.

People on social media also took a dig at the new rules and questioned the scientific rationale behind it.

One Twitter user wrote, “Make it compulsory for every central minister and BABU (government employees) to undergo surgery by Ayurveda MS people and you will see the law disappear.”

Another user said the government will next pass directive which “allows cobblers and tailors to give post-operative stitches, butchers to conduct throat surgeries and fish sellers to conduct a post-mortem.”

Read More
medicine

Compounds in traditional Chinese medicine herbs may inhibit SARS-CoV-2 infection

Using computational methods, a team of researchers identified three compounds in traditional Chinese medicine that could be used against SARS-CoV-2: quercetin, puerarin and kaempferol​.  Of the three compounds, quercetin showed the highest binding affinity to both the ACE2 receptor and the receptor-binding domain of the SARS-CoV-2 spike protein, and could thus provide a dual synergistic effect.  

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of the ongoing coronavirus disease 2019 (COVID-19) pandemic, infects human hosts by binding with the human angiotensin-converting enzyme 2 (ACE2) receptor on their cells, notably the epithelium lining the respiratory tract. The receptor-binding domain (RBD) of the coronavirus spike protein binds to ACE2 followed by membrane fusion to the host cell, thus allowing the virus to infiltrate the cell and commence replication.

Traditional Chinese medicine, widely used for many diseases, showed therapeutic effects during the 2003 SARS-CoV epidemic. The RBD of the SARS-CoV-2 has significant structural homology with SARS-CoV. Although the use of Chinese herbs with modern medicine has shown benefits in COVID-19 patients, several components are present in the herbs and have complex interactions, making it challenging to uncover the molecular mechanisms responsible for its therapeutic effects.

Study: Chinese herbal compounds against SARS-CoV-2: puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. Image Credit: Dragon Images / Shutterstock

Several computational studies have helped predict active compounds in the medicinal herbs with the potential to accelerate traditional medicine-based drug discovery.

Finding potential compounds against SARS-CoV-2

Researchers from various institutions in China used computational analysis to discover potential molecule candidates against SARS-CoV-2 infection. Using the Traditional Chinese Medicine Pharmacology database, they screened for molecules that could target ACE2.

They identified the compound puerarin that could target ACE2. Then, they screened for Chinese herbs that have this compound in the database and found five. Furthermore, since it is thought that compounds in the same herbal medicine have synergistic properties, they expanded their search to include all the compounds in the five herbs to arrive at 41 compounds.

Upon analyzing which compounds were present in the maximum number of herbs, they found puerarin was present in all the five herbs, and quercetin and kaempferol were present in three herbs. Next, they predicted potential drug targets of the selected compounds using the database, leading to 240 possible targets. Upon further analysis, they selected puerarin, quercetin, and kaempferol for further study.

Next, the authors performed molecular docking analysis to determine potential binding sites and binding affinity to ACE2. All the three compounds could bind on the same region of ACE2, which is located some distance from the binding position of SARS-CoV-2. It is likely the compounds are causing changes in conformations rather than competing with the spike protein to bind to ACE2. Quercetin had the highest binding affinity, forming both strong and weak hydrogen bonds.

Quercetin could bind to RBD domain of S-protein with a high binding affinity. (A) Hydrophilic-hydrophobic interaction between (i) quercetin and SARS-CoV-2 Spike in candidate protein binding pocket, and (ii) quercetin and relative amino acids. (B) The KD of the SARS-CoV-2 Spike RBD protein with a series of concentrations of quercetin was calculated by SPR.

Quercetin could bind to RBD domain of S-protein with a high binding affinity. (A) Hydrophilic-hydrophobic interaction between (i) quercetin and SARS-CoV-2 Spike in candidate protein binding pocket, and (ii) quercetin and relative amino acids. (B) The KD of the SARS-CoV-2 Spike RBD protein with a series of concentrations of quercetin was calculated by SPR.

Read More
medicine

WHO selects India to set up traditional medicine centre : The Tribune India

Tribune News Service
New Delhi, November 13

Prime Minister Narendra Modi today dedicated two future-ready Ayurveda institutions to the nation to mark the 5th Ayurveda Day even as the World Health Organisation chose India to host a centre for traditional medicine.

Inaugurating virtually The Institute of Teaching & Research in Ayurveda (ITRA) at Jamnagar (an Institute of national importance) and the National Institute of Ayurveda (NIA) in Jaipur (a deemed university), the PM said the world was increasingly embracing traditional medicine. He said the exports of ayurvedic products had risen 45 per cent this September compared to last year.

During the event today, WHO Director General Tedros Adhanom Ghebreyesus gave a video message announcing that the WHO had decided to establish a Global Centre of Traditional Medicine in India.

Hailing the WHO decision, PM Modi said, “Ayurveda is Indian heritage and it is a matter of happiness that India’s traditional knowledge is enriching other countries too.” He said the need of the hour was to bring ayurveda knowledge out of books, scriptures and home remedies and develop this ancient knowledge as per modern needs. He said work was on to develop the National Sowa-Rigpa Institute for Research and other studies related to Sowa-Rigpa in Leh.

Calling upon the Education Ministry and the UGC to find new avenues in disciplines like ayurveda physics and ayurveda chemistry, the PM said start-ups and private sector should study the global trends and demands and ensure their participation in the sector.

Modi pointed out that during the corona period, the demand for ayurvedic products had increased rapidly all over the world.

“The exports of ayurvedic products increased by 45 per cent in September this year compared to the previous year. There has been a significant increase in exports of spices like turmeric and ginger, considered immunity boosters. This shows the sudden boost in confidence in ayurvedic solutions and Indian spices in the world,” he said.


Modi hails decision

The export of ayurvedic products has increased . There has been a significant rise in the export of spices like turmeric and ginger, considered immunity boosters. The confidence in ayurvedic solutions and Indian spices is growing. — Narendra Modi, Prime Minister

Medicine strategy

This new centre will support our efforts to implement WHO’s traditional medicine strategy, which aims to support nations in developing policies & action plans to strengthen the role of traditional medicine as part of their journey to universal health coverage. — TA Ghebreyesus, WHO chief

Source Article

Read More
medicine

WHO to set up centre for traditional medicine in India, PM Modi says matter of pride



a sign on the side of a building


© Provided by Zee Business


The World Health Organisation announced on Friday that it will set up a Global Centre for Traditional Medicine in India, with Prime Minister Narendra Modi expressing confidence that just like the country has emerged as the ‘pharmacy of the world’, the WHO institution will become the centre for global wellness.

WHO Director General Tedros Adhanom Ghebreyesus made the announcement in a video message at an event in which Prime Minister Modi dedicated two future-ready Ayurveda institutions in Jaipur and Jamnagar to the nation via video conferencing on the occasion of the 5th Ayurveda Day.

The Institute of Teaching and Research in Ayurveda (ITRA), Jamnagar (Gujarat) and the National Institute of Ayurveda (NIA), Jaipur (Rajasthan) are both premier institutions of Ayurveda in the country.

The Jamnagar institute has been conferred the status of an Institution of National Importance (INI) by an act of Parliament and the one at Jaipur has been designated an Institution Deemed to be University (De novo Category) by the University Grants Commission (UGC), according to the AYUSH ministry.

In his video message, Ghebreyesus said, “I am pleased to announce that we have agreed to open a WHO Global Centre of Traditional Medicine in India to strengthen the evidence, research, training and awareness of traditional and complementary medicine.”

“This new centre will support WHO’s efforts to implement the WHO traditional medicine strategy 2014-2023 which aims to support countries in developing policies and action plans to strengthen the role of traditional medicine as part of their journey to universal health coverage and a healthier, fairer and safer world,” he said.

Traditional systems of medicine such as Ayurveda can play an important role in integrated people-centric health services and healthcare, but they have not received enough attention, the WHO DG said.

Ghebreyesus also lauded Prime Minister Modi for his commitment to the universal coverage under Ayushman Bharat and evidence-based promotion of traditional medicines to achieve health related objectives.

Modi said Ayurveda is India’s heritage whose expansion entails the welfare of humanity and all Indians will be happy to see that the country’s traditional knowledge is enriching other countries.

“It is a matter of pride for all Indians that the WHO has chosen India for establishing its Global Centre for Traditional Medicine. Now work will be done in this direction from India,” Modi said.

“I would like to thank the WHO and particularly its Director General Tedros for giving this responsibility to India. I am confident that just like India has emerged as the pharmacy of the world, in the same manner this centre for traditional medicine will become the centre for global wellness,” he said.

Stressing on bringing ayurveda knowledge out of books, scriptures and home remedies and developing this ancient knowledge as per modern needs, Modi said new research is being done in the country by combining information received from modern science of the 21st century with India’s ancient medical knowledge.

Noting that three years ago, the All India Ayurvedic Institute was established here,

Read More
medicine

PM Modi thanks WHO chief for choosing India for global centre of traditional medicine



Narendra Modi looking at the camera: PM Modi thanks WHO chief for choosing India for global centre of traditional medicine


© Saurav Mukherjee
PM Modi thanks WHO chief for choosing India for global centre of traditional medicine

The World Health Organization (WHO) will set up a Global Centre for Traditional Medicine in India to strengthen the evidence, research, training and awareness of traditional and complementary medicine. WHO Director-General Tedros Adhanom Ghebreyesus made the announcement at an event on November 13 in which Prime Minister Narendra Modi inaugurated two future-ready Ayurveda institutions in Jaipur and Jamnagar via video conferencing on the occasion of the 5th Ayurveda Day.

In a video message, Ghebreyesus said, “I am pleased to announce that we have agreed to open a WHO Global Centre for Traditional Medicine in India to strengthen the evidence, research, training and awareness of traditional and complementary medicine.”

“This new centre will support WHO’s efforts to implement its traditional medicine strategy 2014-2023 which aims to support countries in developing policies and action plans to strengthen the role of traditional medicine as part of their journey to universal health coverage and a healthier, fairer and safer world,” he said.

Ghebreyesus praised PM Modi’s commitment to the universal coverage under Ayushman Bharat and evidence-based promotion of traditional medicines to achieve health-related objectives, the Prime Minister’s Office said in a statement.

The Prime Minister thanked WHO and its Director-General for choosing India as the Global Centre of Traditional medicine.

I am thankful Director General of @WHO, @DrTedros for choosing #India for Global Centre of Traditional medicine: PM @narendramodi #NationalAyurvedaDay https://t.co/a9vyzOYdXD pic.twitter.com/YwyVYq9SaL

— PIB India (@PIB_India) November 13, 2020

“It is a matter of pride for all Indians that the WHO has chosen India for establishing its Global Centre for Traditional Medicine. Now work will be done in this direction from India,” Modi said.

“I would like to thank the WHO and particularly its Director General Tedros for giving this responsibility to India. I am confident that just like India has emerged as the pharmacy of the world, in the same manner this centre for traditional medicine will become the centre for global wellness,” he said.

(With inputs from PTI)

Source Article

Read More
medicine

WHO to set up centre for traditional medicine in India; PM Modi calls it ‘matter of pride’- The New Indian Express

By PTI

NEW DELHI: The World Health Organisation announced on Friday that it will set up a Global Centre for Traditional Medicine in India, with Prime Minister Narendra expressing confidence that just like the country has emerged as the ‘pharmacy of the world’, the WHO institution will become the centre for global wellness.

WHO Director-General Tedros Adhanom Ghebreyesus made the announcement in a video message at an event in which Prime Minister Modi dedicated two future-ready Ayurveda institutions in Jaipur and Jamnagar to the nation via video conferencing on the occasion of the 5th Ayurveda Day.

The Institute of Teaching and Research in Ayurveda (ITRA), Jamnagar (Gujarat) and the National Institute of Ayurveda (NIA), Jaipur (Rajasthan) are both premier institutions of Ayurveda in the country.

The Jamnagar institute has been conferred the status of an Institution of National Importance (INI) by an act of Parliament and the one at Jaipur has been designated an Institution Deemed to be University (De novo Category) by the University Grants Commission (UGC), according to the AYUSH ministry.

In his video message, Ghebreyesus said, “I am pleased to announce that we have agreed to open a WHO Global Centre of Traditional Medicine in India to strengthen the evidence, research, training and awareness of traditional and complementary medicine.

” “This new centre will support WHO’s efforts to implement the WHO traditional medicine strategy 2014-2023 which aims to support countries in developing policies and action plans to strengthen the role of traditional medicine as part of their journey to universal health coverage and a healthier, fairer and safer world,” he said.

Traditional systems of medicine such as Ayurveda can play an important role in integrated people-centric health services and healthcare, but they have not received enough attention, the WHO DG said.

Ghebreyesus also lauded Prime Minister Modi for his commitment to the universal coverage under Ayushman Bharat and evidence-based promotion of traditional medicines to achieve health related objectives.

Modi said Ayurveda is India’s heritage whose expansion entails the welfare of humanity and all Indians will be happy to see that the country’s traditional knowledge is enriching other countries.

“It is a matter of pride for all Indians that the WHO has chosen India for establishing its Global Centre for Traditional Medicine.

Now work will be done in this direction from India,” Modi said.

“I would like to thank the WHO and particularly its Director General Tedros for giving this responsibility to India.

I am confident that just like India has emerged as the pharmacy of the world, in the same manner this centre for traditional medicine will become the centre for global wellness,” he said.

Stressing on bringing ayurveda knowledge out of books, scriptures and home remedies and developing this ancient knowledge as per modern needs, Modi said new research is being done in the country by combining information received from modern science of the 21st century with India’s ancient medical knowledge.

Noting that three years ago, the All India Ayurvedic Institute was established here, he said

Read More